PACLITAXEL INJECTION 100MG/16.7ML – Third Party Manufacturing | Medizia Biotech

Paclitaxel Injection 100mg/16.7ml is a high-quality anti-cancer chemotherapy injection manufactured by Medizia Biotech, a trusted pharmaceutical company specializing in oncology products. We provide third party manufacturing and contract manufacturing services for Paclitaxel Injection with strict adherence to WHO-GMP quality standards, advanced manufacturing processes, and comprehensive quality control.

Medizia Biotech offers customized manufacturing solutions for pharmaceutical companies, hospitals, healthcare institutions, government tenders, distributors, exporters, and bulk buyers. Our manufacturing services include private labeling, customized packaging, regulatory documentation support, and timely delivery to meet domestic and international market requirements.

Paclitaxel Injection is widely used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer, Kaposi's sarcoma, and other oncology indications as prescribed by qualified healthcare professionals.

Why Choose Medizia Biotech?

• WHO-GMP compliant manufacturing facility

• Third party manufacturing for oncology injectables

• Contract manufacturing with private labeling

• Small batch and bulk manufacturing available

• Premium quality pharmaceutical formulations

• Reliable bulk supply across India and international markets

• Competitive pricing with timely delivery

• Experienced regulatory and quality assurance team

For reliable Paclitaxel Injection 100mg/16.7ml Third Party Manufacturing, partner with Medizia Biotech for consistent quality, dependable supply, and professional manufacturing solutions.